How Bill Gates Could Transform Alzheimer's Disease

America is finally making progress addressing our Alzheimer’s Problem. Particularly inspiring are discoveries of biomarker measures that allow physicians to accurately diagnose the disease early in its course. We’re also making progress in discovering treatments. Just last week, at the Alzheimer’s Association International Conference in Chicago, we learned that lowering blood pressure might reduce the risk of mild cognitive impairment, a condition that can worsen to dementia, and that Biogen’s antibody that targets brain amyloid might slow decline in persons with mild stage Alzheimer’s disease dementia.

Truly, this progress isn’t surprising. Americans are a can-do, “put a man on the moon” people. We’re really good at discovering and monetizing biomedical diagnostics and treatments. Why then has Bill Gates, a great American innovator and philanthropist, made the discovery of Alzheimer’s diagnostics and treatments the focus of his philanthropy?

To read the entire article, click HERE